System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Michela Cortesi is an expert in Biochemistry at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (Italy). Michela Cortesi has authored 69 publications, the most recent in 2026. SLR score: 175 (community average: 125). How the SLR is computed.

LeadR Profile

Michela Cortesi Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Italy
175 ScienceLeadR Reputation 175

Unlock

Register Login
Network Map

Biochemistry

Subspecialties: Oncology - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2008 - 2026
Source: PubMed

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 69

Citations

Citations: 1 450 1st author: 13 Last author: 2 Unique author: 0

Main journals

Cancer Res 6
Phys Rev Lett 6
Int J Mol Sci 5
Front Chem 2
Front Pharmacol 2

Best Journals

Ann Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Editorial: Molecular and functional profiling in breast cancer: implications for hereditary and sporadic cases.
PMID 41737489 — breast neoplasms, neoplasms, breast		Front Oncol20260
Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study.
PMID 41264030 — cytokines, breast neoplasms, neoplasms, signs and symptoms, breast, climacteric, therapeutics, palliative care, acupuncture		Support Care Cancer20250
Liquid biopsy perspectives in pleomorphic carcinoma of the lung: case report.
PMID 40673099 — cells, lung, blood, neoplasms, biopsy, lung neoplasms, diagnosis, tissues, liquid biopsy		Transl Lung Cancer Res20250
Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneity.
PMID 40329429 — cells, neoplastic cells, circulating, breast neoplasms, neoplasms, neoplasm metastasis, breast		Exp Hematol Oncol20250
FAP inhibitors: are we really using the best method to evaluate the residence time?
PMID 40000458 — nuclear medicine		Eur J Nucl Med Mol Imaging20250

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS